The newly launched Geneo life sciences hub in Singapore is poised to enhance collaboration and innovation in the sector.
Located in Science Park, Geneo aims to create a dynamic ecosystem for both established firms and startups in the life sciences industry. Officially opened by CapitaLand, the hub encompasses three properties with a significant portion dedicated to biomedical research and development. With over 80% of its space already occupied, it is attracting multinational companies like Barry Callebaut and Henkel, who are expanding their operations in the region.
Geneo's strategic location near the National University of Singapore and National University Hospital fosters collaboration opportunities, enhancing the potential for interdisciplinary research. The hub not only features cutting-edge laboratories but also amenities such as food outlets and serviced apartments, aiming to transform the area into a vibrant work-live-play environment.
CapitaLand’s CEO, Jonathan Yap, emphasizes the importance of cultivating a diverse tenant mix to facilitate knowledge transfer and innovation. The ecosystem is expected to support mentorship programs and collaborative initiatives, further enhancing Singapore's position as a central hub for life sciences research and development.
This initiative aligns with Singapore's broader strategy to develop sector-focused hubs, reinforcing its appeal as a collaborative and agile environment for businesses in the life sciences sector. As companies like Barry Callebaut and NSG Bio expand their operations, Geneo is set to play a crucial role in driving forward the region's innovation landscape.